Vivani Medical Inc./$VANI
1D1W1MYTD1Y5YMAX
About Vivani Medical Inc.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
- Ticker
- $VANI
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 42
- Headquarters
- Alameda, United States
- Website
- www.vivani.com
VANI Metrics
BasicAdvanced
$128M
-
-$0.35
3.28
-
Price and volume
Market cap
$128M
Beta
3.28
52-week high
$1.92
52-week low
$0.92
Average daily volume
177K
Financial strength
Current ratio
3.249
Quick ratio
3.094
Long term debt to equity
84.426
Total debt to equity
94.142
Profitability
EBITDA (TTM)
-26.879
Management effectiveness
Return on assets (TTM)
-48.48%
Return on equity (TTM)
-220.40%
Valuation
Price to book
6.69
Price to tangible book (TTM)
6.69
Price to free cash flow (TTM)
-4.012
Free cash flow yield (TTM)
-24.93%
Free cash flow per share (TTM)
-0.354
Growth
Earnings per share change (TTM)
-20.46%
3-year earnings per share growth (CAGR)
-5.30%
VANI News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.